JPRN-UMIN000032899
Completed
未知
Investigation of prediction abilities for a risk of hypoglycemia of intermediate-term glycemic variability metrics using continuous glucose monitor data - Prediction ability for hypoglycemia
Inuyama Chuo General Hospital0 sites104 target enrollmentJune 7, 2018
Conditionstype 2 diabetes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- type 2 diabetes
- Sponsor
- Inuyama Chuo General Hospital
- Enrollment
- 104
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •judged to be unsuitable for participation for medical reasons
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A risk-predictive score for developing Non-Alcoholic Fatty Liver Disease (NAFLD) using biochemical markersHealth Condition 1: K758- Other specified inflammatory liverdiseasesCTRI/2022/12/048328PG Grants, Kasturba Medical College
Active, not recruiting
Phase 1
Prospective evaluation of the predictive value of a circulating tumor cell (CTC) sensitivity profile to Cisplatin chemotherapy in metastatic breast cancer patientsMetastatic breast cancerTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-005395-34-NLErasmus MC72
Recruiting
Not Applicable
Prognostic modeling for an efficacy and a safety of thrombolysis with acute ischemic stroke patientsDiseases of the nervous systemKCT0000242Seoul National University Bundang Hospital1,890
Recruiting
Not Applicable
Construction of a Risk Prediction Model for Cognitive Dysfunction Accompanied by Anxiety State Combined with Disease SyndromeITMCTR2024000087Jilin University of Traditional Chinese Medicine
Completed
Not Applicable
Practical risk stratification score for prediction of contrast-induced nephropathy after primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction: development and internal validatioContrast-induced nephropathy was defined as the deterioration of renal function following the administration of contrast agents and unlikely to be explained by other possible causes. Patients with anprediction score,contrast-induced nephropathy,STEMITCTR20190705001/A217